Snowden Capital Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $806K | Buy |
|
|||||
|
2025
Q2 | $721K | Buy |
|
|||||
|
2025
Q1 | $596K | Sell |
|
|||||
|
2024
Q4 | $812K | Buy |
|
|||||
|
2024
Q3 | $676K | Sell |
|
|||||
|
2024
Q2 | $1.41M | Sell |
|
|||||
|
2024
Q1 | $1.43M | Sell |
|
|||||
|
2023
Q4 | $1.43M | Buy |
|
|||||
|
2023
Q3 | $1.15M | Buy |
|
|||||
|
2023
Q2 | $955K | Buy |
|
|||||
|
2023
Q1 | $496K | Buy |
|
|||||
|
2022
Q4 | $576K | Sell |
|
|||||
|
2022
Q3 | $578K | Buy |
|
|||||
|
2022
Q2 | $405K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $356K | Buy |
|
|||||
|
2021
Q2 | $280K | Buy |
|